PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8144213-8	1994	Lisinopril also increased aortic bradykinin-(1-9) and bradykinin-(1-7) levels at doses below the threshold for the decrease in the ratio of Ang II to Ang I.	Lisinopril	0-10	angiogenin	Rattus norvegicus	140-143	
16221218-1	2005	BACKGROUND: Angiotensin-converting enzyme (ACE)2, a homologue of ACE, which is insensitive to ACE inhibitors and forms angiotensin-(1-7) [Ang-(1-7)] from angiotensin II (Ang II) with high efficiency was investigated in response to chronic blockade with lisinopril, losartan, and both drugs combined.	Lisinopril	253-263	angiogenin	Rattus norvegicus	138-146	
16221218-8	2005	Lisinopril augmented plasma levels and urinary excretion rates of Ang I and Ang-(1-7), while plasma Ang II was reduced with no effect on urinary Ang II.	Lisinopril	0-10	angiogenin	Rattus norvegicus	76-84	
16221218-10	2005	Combination therapy mimicked the effects obtained with lisinopril on plasma and urinary Ang I and Ang-(1-7) levels.	Lisinopril	55-65	angiogenin	Rattus norvegicus	98-106	
33915312-8	2021	We conclude that activating GPER with G1 augments components of the cardiac RAS and improves diastolic function without lowering blood pressure, and that lisinopril-induced blood pressure control and cardiac alterations in OVX SHR are permissive in facilitating G1 to augment Ang-(1-7) in serum, thereby strengthening its cardioprotective benefits.	Lisinopril	154-164	angiogenin	Rattus norvegicus	276-284	
18192334-9	2008	Plasma Ang(1-7) and Ang II balance is positively shifted towards the beneficial vasopeptide Ang(1-7) by the ACE inhibitor lisinopril, especially during a low sodium intake.	Lisinopril	122-132	angiogenin	Rattus norvegicus	7-14	
18192334-9	2008	Plasma Ang(1-7) and Ang II balance is positively shifted towards the beneficial vasopeptide Ang(1-7) by the ACE inhibitor lisinopril, especially during a low sodium intake.	Lisinopril	122-132	angiogenin	Rattus norvegicus	92-99